198 related articles for article (PubMed ID: 1648690)
1. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
[TBL] [Abstract][Full Text] [Related]
2. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
3. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
[TBL] [Abstract][Full Text] [Related]
6. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
[TBL] [Abstract][Full Text] [Related]
7. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra.
Benoliel JJ; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1992 Mar; 58(3):916-22. PubMed ID: 1310726
[TBL] [Abstract][Full Text] [Related]
8. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
[TBL] [Abstract][Full Text] [Related]
9. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
10. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
[TBL] [Abstract][Full Text] [Related]
11. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
[TBL] [Abstract][Full Text] [Related]
12. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
13. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
Miaskowski C; Taiwo YO; Levine JD
Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
[TBL] [Abstract][Full Text] [Related]
14. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G
Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
16. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
17. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
Feuerstein G; Powell E; Faden AI
Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
[TBL] [Abstract][Full Text] [Related]
18. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.
Hope PJ; Fleetwood-Walker SM; Mitchell R
Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
